The Swiss voice in the world since 1935

Pfizer/BioNTech vaccine approved for children by Swiss regulator

vaccines
Keystone / Pablo Gianinazzi

The Swiss medical regulator has approved the use of Pfizer/BioNTech’s Covid-19 vaccine for children aged five to 11. However, the Federal Vaccination Commission has yet to recommend extending the immunisation campaign to this group.

“The clinical trial results show that the vaccine is safe and effective in this age group,” wrote Swissmedic on FridayExternal link. It said an ongoing study involving more than 1,500 people showed “almost complete protection against serious illness” caused by Covid-19 among those aged five to 11 and that side effects tended to occur less frequently than in adolescents or adults.

These side effects – slightly more frequent after the second dose – can include pain at the point of injection, tiredness, and occasionally headaches, joint pain, or fever.

The regulator recommends two doses of the vaccine, three weeks apart, but at just one-third the strength of a normal adult dose.

However, a recommendation by the Federal Vaccination Commission would be needed before the national immunisation strategy would be updated to include this age group, Swissmedic told the Keystone-SDA news agency.

As of Friday evening, the website of the Federal Office of Public Health indicated that “currently there are no plans to vaccinate children under 12”.

Moderna waiting

Meanwhile, Moderna’s Spikevax vaccine is still under review by Swissmedic for use on children, with no decision yet taken. The Janssen viral vector vaccine, the third being used on adults in Switzerland, has not been submitted for consideration on children.

Overall, despite efforts by authorities to spur interest, the Swiss are still among the most reluctant to vaccinate in Western Europe; as of Friday, some 68% of the population had received at least one vaccine dose, amounting to around 78% of the adult (aged 19 and above) population.

More

Popular Stories

News

Safra Sarasin and a former asset manager sentenced

More

Swiss Politics

Safra Sarasin private bank and former asset manager sentenced

This content was published on The Office of the Attorney General of Switzerland has fined private bank J. Safra Sarasin CHF3.5 million for aggravated money laundering. A former bank employee received a six-month suspended prison sentence.

Read more: Safra Sarasin private bank and former asset manager sentenced
1MDB affair: JPMorgan to pay CHF 270 million

More

Swiss Politics

JPMorgan to pay CHF270 million to settle 1MDB claims

This content was published on JPMorgan Chase has agreed to pay CHF270 million to the Malaysian government to settle all issues related to its role in the 1MDB financial scandal.

Read more: JPMorgan to pay CHF270 million to settle 1MDB claims
Philippe Lazzarini has overseen UNRWA since 2020.

More

Foreign Affairs

UNRWA boss Lazzarini to step down in March 2026

This content was published on Philippe Lazzarini will step down as head of the United Nations Relief and Works Agency for Palestinian Refugees (UNRWA) at the end of his term in March, he announced on Thursday.

Read more: UNRWA boss Lazzarini to step down in March 2026
Gösgen NPP outage darkens profit prospects for Axpo and Alpiq

More

Swiss Politics

Outage extended at Swiss nuclear plant

This content was published on The Gösgen nuclear power plant in northwestern Switzerland will be out of service for six months. It has not been connected to the grid since late May.

Read more: Outage extended at Swiss nuclear plant

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR